Click here to see a list of our past events.
Center for Technology Licensing (CTL) at Weill Cornell Medicine Office Hours with Eric Bryant are open to all who wish to get answers to their intellectual property questions and gain more information about the advancement of their IP filings with a one-on-one meeting.
The Tuesday, June 17, office hours will be hosted virtually by Eric Bryant, M.S., J.D., Intellectual Property Officer, Biomedical Sciences.
Eric holds a Master of Science in Biomedical Engineering from New York University, a Juris Doctor from New York Law School, and is a registered patent attorney. He works with the Weill Cornell office to execute on intellectual property strategy, review submitted invention disclosures, and manage domestic and foreign patent filings and patent prosecution. Eric’s expertise encompasses a variety of technologies including, but not limited to, diagnostics tools and methods, pharmaceuticals, controlled release therapeutic devices, respiratory devices, surgical tools, biological technologies and nanotechnology.
To reserve your private, 30-minute Zoom session with Eric, click here. Click the right arrow on top of the calendar to choose the month of June and click 17 to choose the time you prefer.
Do you have ideas for a new medical device to improve patient care or a tool to support your current medical training objectives? Do you need assistance translating these ideas into a graphic design and printing a 3D prototype?
Join us on Friday, June 13 for an introductory 3D printing class in the BioVenture eLab's MakerSpace. Learn 3D printing basics and how to workshop your medical device projects. In addition to learning how to use specialized software and Google Sketch to create designs for 3D printing, topics covered in this seminar will include:
- biodesign concepts
- how to use design software to refine and augment your designs
- tips for using a 3D printer to generate an initial prototype
The seminar will feature NatalieDeana Badillo, a Weill Cornell Medicine medical student and CTSC TL-1 trainee who possesses a biomedical engineering degree. She serves as Co-President of the Bioengineering Interest Group (BIG) and 3D Printing Liaison for the Samuel J. Wood Library at Weill Cornell Medicine.
Register here.
In this virtual course (held July 7 - August 6), researchers working on a deep tech innovation “get out of your comfort zone” and talk with customers (virtually) to identify the best product-market fit. You may apply with a team of 1-3 people. Teams may not split attendance between members. Please only include the members of your team that will be fully participating in the course. All team members are required to attend and participate fully in every course session and complete all coursework.
Apply here. Questions? Contact icorps@cornell.edu or visit https://www.in-icorps.org/regional-courses/.
Join Rev: Ithaca Startup Works for a virtual session on public relations for startups and learn how to tell your brand’s story effectively to build awareness, credibility and investor interest. Public relations is an indispensable tool for startups aiming to grow and scale.
Led by Melissa Musiker DNS ’03, former Senior Director of International Public Affairs and Issues Management for corporate McDonald’s, will speak on public relations for startups. Musiker brings decades of global PR experience to help founders and entrepreneurs craft compelling narratives, manage media relationships, and build lasting brand credibility.
Admission is free and open to all — whether you're building a company, launching a product or just curious about the power of PR. RSVP today.
Ahead of the BIO International Convention in Boston (June 16–19), join us for a special pre-conference webinar with Jennifer Hawks Bland, CEO of NewYorkBIO.
As the head of NewYorkBIO, Jennifer brings a unique perspective from the frontlines of New York’s dynamic life sciences ecosystem. Did you know:
- Over 60% of large pharmaceutical national or global headquarters are located in the New York area
- The state supports more than 75,000 direct biotechnology jobs
- New York graduates more life science PhDs than any other U.S. region
- It hosts more than 25% of all clinical trials in the U.S.
- And it's home to the world’s largest concentration of academic medical centers
With this incredible foundation, there will be no shortage of important topics to explore. The agenda includes questions about the new Life Science Talent Network, NewYorkBIO’s extensive advocacy work, and resources available to innovators/startups seeking funding.
Whether you're a researcher, clinician, startup founder, investor or simply passionate about the future of health care, this is a conversation you won’t want to miss.
RSVP here.
Center for Technology Licensing (CTL) at Weill Cornell Medicine Office Hours are open to all who wish to gain more information about the advancement of their patent filings and to discuss their technology venture project with a one-on-one meeting with a Weill Cornell Business Development and Licensing Professional. The June 5th office hours will be hosted by Donna Rounds, Ph.D., Associate Director, Business Development and Licensing.
Donna joined the startup world as one of the founders of Physiome Sciences, Inc., the first in-silico drug discovery platform using computational models of cells, tissues and organs. She later joined the British Technology Group (BTG Plc) as a technology scout, where she visited academic institutions across the East Coast searching for biotech projects in the early stages of development. Later, Donna joined Columbia Technology Ventures (CTV) and managed a portfolio of world-class scientists and Nobel laureates at Columbia University Vagelos College of Physicians and Surgeons. She was later recruited to lead the technology development program at Hospital for Special Surgery with a focus on musculoskeletal innovations and medical devices in orthopedics and rheumatology. Donna was on the scientific advisory board of Tohi Ventures and co-founded Nirova BioSense, which is dedicated to the development of optical sensors for real-time detection of ovarian cancer biomarkers.
Register here for your 30-minute private session. Click the right arrow on top of the calendar to choose the month of June and click 5 on the June calendar to choose the time you prefer.
Join us for an insightful panel discussion on the critical challenges and opportunities in bringing pharmaceutical innovations to market. This dynamic session will explore key aspects of the drug commercialization journey, including regulatory strategy and market access considerations. Panelists will share their experiences in successfully launching new therapeutics while addressing evolving health care landscapes and stakeholder demands.
Panelists:
- Alexander Brown, COO of Convergent Therapeutics
- Dr. Neil Bander, CSO, Co-Founder of Convergent Therapeutics
- Dr. Philip Kantoff, CEO, Co-Founder of Convergent Therapeutics
- Dr. Scott Tagawa, Professor of Medicine at Weill Cornell Medicine
Hosted by Brian Kelly, director of technology licensing at Weill Cornell Medicine
Center for Technology Licensing (CTL) at Weill Cornell Medicine Office Hours are open to all who wish to gain more information about the advancement of their patent filings and to discuss their technology venture project with a one-on-one meeting with a Weill Cornell Business Development and Licensing Professional. The May 22nd office hours will be hosted by Jamie Brisbois, Ph.D., Manager, Business Development and Licensing.
Jamie collaborates with Weill Cornell Medicine innovators to identify, market and license life sciences technologies. Prior to joining the Center for Technology Licensing in 2021, Jamie worked as a consultant with ClearView Healthcare Partners, a boutique health care consulting firm based in Boston. In addition, he served three years as a fellow with Columbia Technology Ventures (CTV), the technology transfer office of Columbia University.
Register here for your 30-minute private session.
Join us for a virtual presentation exploring the practical implications of incorporating artificial intelligence (AI) tools in academic research and innovation. As AI becomes increasingly integrated into research methodologies, understanding how to properly document and manage AI assistance in the invention process is crucial for protecting intellectual property rights.
This interactive session will address key concerns facing researchers, including:
- Strategic approaches to incorporating AI tools in your research workflow
- Best practices for documenting AI assistance during invention conception and development
- Practical guidelines for maintaining transparent records of AI interactions (prompts and outputs)
- Protecting IP potential while leveraging AI capabilities
- Understanding the concept of hybrid inventorship in the AI era
Hosted by Martin Teschl, Director of BD & Licensing, our guest speaker David Sanker, Founder of Sanker IP, will provide actionable insights and practical frameworks for researchers looking to optimize their use of AI while safeguarding their intellectual property interests.
An infusion of non-dilutive funding like SBIR/STTR grants can propel a startup forward — but what comes after you win? Entrepreneurs are invited to join Rev: Ithaca Startup Works and Renata Dabrowska, CPA at Sciarabba Walker & Co., LLP, for a virtual content session focused on the crucial accounting steps after receiving an SBIR or STTR award.
In this informative session, Dabrowska will demystify post-award requirements and share best practices for compliant and strategic financial management. From setting up proper accounting systems to managing federal reporting and audits, attendees will walk away with actionable insights to help their ventures stay on track.
Admission is free and open to all. RSVP today.
